Literature DB >> 363986

Review of factors contributing to dry socket through enhanced fibrinolysis.

J E Catellani.   

Abstract

Use of oral contraceptives and trauma during extraction are substantiated factors that contribute to dry socket. They appear to act by enhancing fibrinolytic activity in the alveolar bone followed by lysis of the clot. The influence of bacteria and antibiotics on the development and prevention of dry socket remains unclear. No convincing evidence can be found that factors such as age, sex, or nutritional status affect the incidence of dry socket.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 363986

Source DB:  PubMed          Journal:  J Oral Surg        ISSN: 0022-3255


  5 in total

Review 1.  Alveolar osteitis following surgical removal of mandibular third molars.

Authors:  K L Fridrich; R A Olson
Journal:  Anesth Prog       Date:  1990 Jan-Feb

2.  [Antimicrobial photodynamic therapy for prevention of alveolar ostitis and post-extraction pain].

Authors:  J Neugebauer; M Jozsa; A Kübler
Journal:  Mund Kiefer Gesichtschir       Date:  2004-09-29

3.  Alveolar osteitis: a comprehensive review of concepts and controversies.

Authors:  Antonia Kolokythas; Eliza Olech; Michael Miloro
Journal:  Int J Dent       Date:  2010-06-24

4.  Experimental alveolitis in rats: microbiological, acute phase response and histometric characterization of delayed alveolar healing.

Authors:  Moacyr Tadeu Vicente Rodrigues; Camila Lopes Cardoso; Paulo Sérgio Perri de Carvalho; Tânia Mary Cestari; Magda Feres; Gustavo Pompermaier Garlet; Osny Ferreira
Journal:  J Appl Oral Sci       Date:  2011 May-Jun       Impact factor: 2.698

5.  Oxytetracycline-hydrocortisone ointment reduces the occurrence of both dry socket and post-extraction pain after third molar extraction: An observational study.

Authors:  Hiroki Otake; Yoko Sato; Eiji Nakatani; Philip Hawke; Shingo Takei; Akihiko Ogino; Hideaki Asai; Atsushi Abe; Kohta Fukuta; Moriyasu Adachi
Journal:  PLoS One       Date:  2021-07-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.